Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.
Duncan JS, Whittle MC, Nakamura K, Abell AN, Midland AA, Zawistowski JS, Johnson NL, Granger DA, Jordan NV, Darr DB, Usary J, Kuan PF, Smalley DM, Major B, He X, Hoadley KA, Zhou B, Sharpless NE, Perou CM, Kim WY, Gomez SM, Chen X, Jin J, Frye SV, Earp HS, Graves LM, Johnson GL.
Duncan JS, et al. Among authors: johnson gl, johnson nl.
Cell. 2012 Apr 13;149(2):307-21. doi: 10.1016/j.cell.2012.02.053.
Cell. 2012.
PMID: 22500798
Free PMC article.